AMLX

Amylyx Pharmaceuticals, Inc.

1.79 USD
-0.05 (-2.72%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Amylyx Pharmaceuticals, Inc. stock is down -9.6% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 May’s closed higher than April. In the last 3 Unusual Options Trades, there were 3 PUTs. 50% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
26 Mar 19:15 17 May, 2024 12.00 PUT 50 366
26 Mar 19:15 17 May, 2024 8.00 PUT 50 316
09 May 14:10 15 Nov, 2024 2.00 PUT 500 5790

About Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc. develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product candidature includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and tauroursodeoxycholic acid.

  • Mizuho
    Tue May 14, 06:46
    hold
    confirm
  • HC Wainwright & Co.
    Fri May 10, 08:24
    buy
    confirm